Cited 1 times in
Safety of Live Immunization in DiGeorge Syndrome: A Retrospective Single-Center Study in Korea, 2005-2021
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 강지만 | - |
dc.contributor.author | 안종균 | - |
dc.contributor.author | 임성민 | - |
dc.contributor.author | 백지연 | - |
dc.date.accessioned | 2023-03-03T03:00:15Z | - |
dc.date.available | 2023-03-03T03:00:15Z | - |
dc.date.issued | 2022-12 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/192958 | - |
dc.description.abstract | Live immunization is contraindicated in patients with DiGeorge syndrome (DGS). We retrospectively investigated the occurrence of adverse events after live immunization in patients with DGS in Korea. The data of patients matching the International Classification of Disease-10 code of DGS (D82.1) at Severance Hospital Seoul, Korea, were extracted; patients without genetically diagnosed DGS were excluded. Based on T cell immunity status, the included patients were categorized into group A (CD3 < 500 or CD8 < 200 cells/mm3); group B (CD3 ≥ 500 and CD8 ≥ 200 cells/mm3); or group C (unknown). Among 94 patients, 38 (~40%, group A: 8 [21%]; group B: 30 [79%]) underwent immunological testing and 73 (~80%) received at least one live immunization (measles-mumps-rubella vaccination was most common [66/94, ~70%]). Fifty adverse events (fever [n = 29], upper respiratory infection [n = 9], diarrhea [n = 4], rash [n = 3], thrombocytopenia [n = 3], injection site pus [n = 1], and febrile convulsion [n = 1]) were observed; 13 (26%) occurred in group A, with no significant difference in incidence between groups A and B. Serious adverse events, including intensive care unit hospitalization or death, or diseases due to vaccine strains were not observed. In this study, live immunization was well tolerated by patients with partial DGS. | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.language | English | - |
dc.publisher | MDPI AG | - |
dc.relation.isPartOf | VACCINES | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Safety of Live Immunization in DiGeorge Syndrome: A Retrospective Single-Center Study in Korea, 2005-2021 | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Pediatrics (소아과학교실) | - |
dc.contributor.googleauthor | Sung Min Lim | - |
dc.contributor.googleauthor | Je Hee Shin | - |
dc.contributor.googleauthor | Jee Yeon Baek | - |
dc.contributor.googleauthor | Ji Young Lee | - |
dc.contributor.googleauthor | Ji-Man Kang | - |
dc.contributor.googleauthor | Jong Gyun Ahn | - |
dc.identifier.doi | 10.3390/vaccines10122165 | - |
dc.contributor.localId | A05720 | - |
dc.contributor.localId | A02261 | - |
dc.contributor.localId | A06325 | - |
dc.relation.journalcode | J03812 | - |
dc.identifier.eissn | 2076-393X | - |
dc.identifier.pmid | 36560575 | - |
dc.subject.keyword | DiGeorge syndrome | - |
dc.subject.keyword | adverse events | - |
dc.subject.keyword | immunodeficiency | - |
dc.subject.keyword | live immunization | - |
dc.subject.keyword | vaccination | - |
dc.contributor.alternativeName | Kang, Ji-Man | - |
dc.contributor.affiliatedAuthor | 강지만 | - |
dc.contributor.affiliatedAuthor | 안종균 | - |
dc.contributor.affiliatedAuthor | 임성민 | - |
dc.citation.volume | 10 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 2165 | - |
dc.identifier.bibliographicCitation | VACCINES, Vol.10(12) : 2165, 2022-12 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.